A federal judge has temporarily blocked a CMS rule on requiring dialysis companies to disclose all charitable premium assistance they provide to patients. 

Basing physician compensation on a pay-for-performance model “simply doesn’t work,” according to a Vox article written by Harvard Medical School population health professor Stephen Soumerai, ScD, and University of Pennsylvania health IT researcher Ross Koppel, PhD.

The rates of opioid related deaths increasing 200 percent since 2000. In order to gauge exactly how bad the epidemic has become, the Agency for Healthcare Research and Quality has released findings in opioid-related statistics by state.

Keeping patients engaged in their own care is easier said than done. Once a patient leaves the doctor’s office, the physician has no way of knowing how committed a patient is until the next appointment. With the integration of patient engagement technology, physicians are giving patients an opportunity to improve care.

Three diabetes care units within Johnson & Johnson (J&J) could be sold, the company said, as it reported slightly better-than-expected earnings for the last quarter of 2016 and lowered expectations for the current year.

The U.S. Food and Drug Administration has announced Hospira, a Pfizer company, has voluntarily recalled one lot of Vancomycin Hydrochloride (VH) at the hospital/retail level in response to the discovery of a particulate matter within a single vial. 

Spina bifida is potentially deadly when untreated. A new review of two different studies reveals the most effective method in using regenerative patches to treat spina bifida using human umbilical cords.

Aetna’s $37 billion acquisition of Humana has been blocked by a federal judge, who ruled it would violate antitrust laws and seriously limit competition in the Medicare Advantage (MA) market and a handful of health insurance exchanges.